Christopher Molineaux, Senior VP, DEVELOPMENT at Calithera Biosciences, Inc. (CALA), bought 51,600 shares at $3.88 ($200K) on 2019-06-25, disclosed to the SEC on 2019-06-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.